It can regulate inflammation, mucus production, tissue remodeling and fibrosis and as a result has become a therapeutic target for many diseases, including asthma, idiopathic pulmonary fibrosis, ulcerative colitis and other IL-13 overexpression diseases [20–22]. This evidence concerns the gene IL13 and idiopathic pulmonary fibrosis.